SMAD1 as a biomarker and potential therapeutic target in drug-resistant multiple myeloma

被引：0
|
作者：
Jian Wu
Min Zhang
Omar Faruq
Eldad Zacksenhaus
Wenming Chen
Aijun Liu
Hong Chang
机构：
[1] University of Toronto,Department of Laboratory Medicine and Pathobiology
[2] Capital Medical University,Department of Hematology, Beijing Chaoyang Hospital
[3] University Health Network,Department of Laboratory Hematology, Laboratory Medicine Program
来源：
Biomarker Research | / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] CS1: A potential new therapeutic target for the treatment of multiple myeloma.
    Hsi, Eric D.
    Steinle, Roxanne
    Balasa, Balaji
    Draksharapu, Aparna
    Shum, Benny
    Huseni, Marukh
    Powers, David
    Nanisetti, Amulya
    Williams, Marna
    Vexler, Vladimir
    Hussein, Mohamad
    Afar, Daniel
    BLOOD, 2006, 108 (11) : 986A - 986A
  • [32] THE HEAT SHOCK TRANSCRIPTION FACTOR 1 IS A NEW POTENTIAL THERAPEUTIC TARGET IN MULTIPLE MYELOMA
    Heimberger, T.
    Andrulis, M.
    Fischbach, S.
    Stuehmer, T.
    Einsele, H.
    Bargou, R.
    Chatterjee, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 139 - 139
  • [33] Multiple drug-resistant tuberculosis
    Bradford, WZ
    Daley, CL
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1998, 12 (01) : 157 - +
  • [34] MULTIPLE DRUG-RESISTANT STYPHIMURIUM
    WALTON, JR
    VETERINARY RECORD, 1989, 124 (23) : 619 - 619
  • [35] SPAG5 as a novel biomarker and potential therapeutic target via regulating AKT pathway in multiple myeloma
    Zeng, Xinyi
    Xu, Wenbin
    Tong, Jianjing
    Liu, Jia
    Zhang, Zilu
    Liu, Mei
    Wu, Chao
    Yu, Qing
    Ye, Chenjing
    Wu, Chengyu
    Wu, Yingli
    Yan, Hua
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2565 - 2572
  • [36] The downstream of Smad1 is the key target of the inhibitory effect of Smad7.
    Katagiri, T
    Imada, M
    Suda, T
    Takahashi, N
    Kamijo, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S439 - S439
  • [37] Therapeutic Advances in Drug-Resistant Epilepsy
    Maynard, Edwin Humberto Hodelin
    Tint, Diana
    Gonzalez, Judith Gonzalez
    Chacon, Lilia Maria Morales
    AMERICAN JOURNAL OF THERAPEUTICS, 2025, 32 (02) : e143 - e150
  • [38] Chitinase-3-like protein 1 may be a potential biomarker in patients with drug-resistant epilepsy
    Zhang, Hua
    Tan, Jia-ze
    Luo, Jing
    Wang, Wei
    NEUROCHEMISTRY INTERNATIONAL, 2019, 124 : 62 - 67
  • [39] IRE1 α-XBP1 signaling pathway, a potential therapeutic target in multiple myeloma
    Chen, Lin
    Li, Qian
    She, Tiantian
    Li, Han
    Yue, Yuanfang
    Gao, Shuang
    Yan, Tinghui
    Liu, Su
    Ma, Jing
    Wang, Yafei
    LEUKEMIA RESEARCH, 2016, 49 : 7 - 12
  • [40] Increased fatty acid synthase as a potential therapeutic target in multiple myeloma
    Wang, Wei-qin
    Zhao, Xiao-ying
    Wang, Hai-yan
    Liang, Yun
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2008, 9 (06): : 441 - 447
12345